Oppenheimer & Co’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5K | Buy |
14,700
+1,200
| +9% | +$1.92K | ﹤0.01% | 1592 |
|
|
2025
Q1 | $16.5K | Buy |
+13,500
| New | +$16.5K | ﹤0.01% | 1555 |
|
|
2024
Q1 | – | Sell |
-1,055
| Closed | -$8.31K | – | 1494 |
|
|
2023
Q4 | $8.31K | Sell |
1,055
-175
| -14% | -$1.38K | ﹤0.01% | 1382 |
|
|
2023
Q3 | $5.44K | Buy |
1,230
+550
| +81% | +$2.43K | ﹤0.01% | 1374 |
|
|
2023
Q2 | $23.7K | Sell |
680
-460
| -40% | -$16K | ﹤0.01% | 1400 |
|
|
2023
Q1 | $24.9K | Buy |
1,140
+25
| +2% | +$545 | ﹤0.01% | 1359 |
|
|
2022
Q4 | $24.1K | Buy |
1,115
+215
| +24% | +$4.64K | ﹤0.01% | 1329 |
|
|
2022
Q3 | $22K | Buy |
900
+200
| +29% | +$4.89K | ﹤0.01% | 1342 |
|
|
2022
Q2 | $14K | Buy |
+700
| New | +$14K | ﹤0.01% | 1395 |
|
|
2022
Q1 | – | Sell |
-1,105
| Closed | -$30K | – | 1553 |
|
|
2021
Q4 | $30K | Buy |
1,105
+460
| +71% | +$12.5K | ﹤0.01% | 1478 |
|
|
2021
Q3 | $28K | Sell |
645
-35
| -5% | -$1.52K | ﹤0.01% | 1479 |
|
|
2021
Q2 | $34K | Buy |
680
+25
| +4% | +$1.25K | ﹤0.01% | 1494 |
|
|
2021
Q1 | $29K | Buy |
+655
| New | +$29K | ﹤0.01% | 1425 |
|
|
2020
Q4 | – | Sell |
-500
| Closed | -$7K | – | 1385 |
|
|
2020
Q3 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 1273 |
|
|
2020
Q2 | – | Sell |
-575
| Closed | -$7K | – | 1302 |
|
|
2020
Q1 | $7K | Buy |
+575
| New | +$7K | ﹤0.01% | 1186 |
|